Evidence map›Paper›PMID 30588102›Full record

ArticleCancer management and research2018

Centromere protein U expression promotes non-small-cell lung cancer cell proliferation through FOXM1 and predicts poor survival.

Xinxin Wang, Diangang Chen, Jianbao Gao, Haixia Long, Haoran Zha, Anmei Zhang, Chi Shu, Li Zhou, Fei Yang, Bo Zhu and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cancer management and research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. The Anaphase-Promoting Complex/Cyclosome Is a Cellular Ageing Regulator.International journal of molecular sciences · 2022
    Review
  3. Article
  4. Article
  5. Germline risk of clonal haematopoiesis.Nature reviews. Genetics · 2021
    Review
  6. Article
  7. High mRNA Expression ofDisease markers · 2021
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Xinxin WangInstitute of Cancer, Xinqiao Hospital, Army Medical University, Chongqing, China, bo.zhu@tmmu.edu.cn.
Diangang ChenInstitute of Cancer, Xinqiao Hospital, Army Medical University, Chongqing, China, bo.zhu@tmmu.edu.cn.
Jianbao GaoInstitute of Cancer, Xinqiao Hospital, Army Medical University, Chongqing, China, bo.zhu@tmmu.edu.cn.
Haixia LongInstitute of Cancer, Xinqiao Hospital, Army Medical University, Chongqing, China, bo.zhu@tmmu.edu.cn.
Haoran ZhaDepartment of Oncology, The General Hospital of the People's Liberation Army Rocket Force, Beijing, China.
Anmei ZhangInstitute of Cancer, Xinqiao Hospital, Army Medical University, Chongqing, China, bo.zhu@tmmu.edu.cn.
Chi ShuInstitute of Cancer, Xinqiao Hospital, Army Medical University, Chongqing, China, bo.zhu@tmmu.edu.cn.
Li ZhouInstitute of Cancer, Xinqiao Hospital, Army Medical University, Chongqing, China, bo.zhu@tmmu.edu.cn.
Fei YangInstitute of Cancer, Xinqiao Hospital, Army Medical University, Chongqing, China, bo.zhu@tmmu.edu.cn.
Bo ZhuInstitute of Cancer, Xinqiao Hospital, Army Medical University, Chongqing, China, bo.zhu@tmmu.edu.cn.
Wei WuDepartment of Cardiothoracic Surgery, Southwest Hospital, Army Medical University, Chongqing, China, wuweiyahoo@sohu.com.
Army Medical University · CNAir Force General Hospital PLA · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeCentromere protein U (CENPU) abnormally exhibits high expression in various types of human tumor tissues and participates in tumor progression; however, its expression pattern and biological function in lung cancer have not yet been elucidated. In the present study, we explored the clinical significance and biological function of CENPU in lung cancer. MATERIALS AND

methodsThe Cancer Genome Atlas (TCGA) data analyses, quantitative real-time PCR (RT-PCR), and Western blotting were performed to quantify CENPU and FOXM1 expression in non-small-cell lung cancer (NSCLC) samples. Survival data were obtained from Kaplan-Meier plotter or PROGgene V2 prognostic database. The function of CENPU in lung cancer cell proliferation was determined using 5-ethynyl-2'-deoxyuridine (EdU), Cell Counting Kit-8 (CCK-8), and cell cycle assays, and the underlying mechanism was determined through bioinformatic analyses and validated by in vitro siRNA or plasmid transfection experiments.

resultsCENPU was abnormally overexpressed in NSCLC samples compared with matched paired normal tissues. Higher expression of CENPU predicted worse overall survival (OS) and relapse-free survival (RFS) in NSCLC patients. Knockdown of CENPU expression by siRNA significantly inhibited proliferation and delayed cell cycle progression of lung cancer cells. To figure out the mechanism, bioinformatic analyses were performed and the results showed that the transcription factor, FOXM1, positively correlated with CENPU. Further in vitro experiments indicated that FOXM1 was the possible downstream transcription factor of CENPU as the knockdown of CENPU led to lower expression of FOXM1 and the overexpression of FOXM1 significantly reversed the inhibition of proliferation caused by CENPU knockdown. Furthermore, FOXM1 was highly expressed in NSCLC. The knockdown of FOXM1 also attenuated proliferation and induced G1 arrest in lung cancer cells.

conclusionCENPU was highly expressed in NSCLC tissues, wherein it promoted lung cancer cell proliferation via the transcription factor, FOXM1, which could be a potential target for therapeutic strategies.

Indexed as

CENPUFOXM1NSCLCproliferation

Identifiers

PMID30588102
PMCPMC6298391
OpenAlexW2903835650

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.